Short answer
aTYR PHARMA INC (ATYR) filed an 8-K current report with the SEC on November 6, 2026 reporting Item 8.01 (Other Events). ATM equity offering of up to $79,994,251 through Jefferies under the existing Sales Agreement.
aTYR PHARMA INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- ATM equity offering of up to $79,994,251 through Jefferies under the existing Sales Agreement
- Potential share issuance creates dilution risk for existing ATYR shareholders
- Flexible at-the-market structure enables incremental funding rather than a single upfront financing
- Proceeds likely strengthen liquidity for corporate and development activities, though use of proceeds is not specified here
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other aTYR PHARMA INC 8-K filings
Get the next ATYR 8-K as it lands
Follow ATYR for push alerts, or ask the research agent what this filing means.